Skip to content

Comparison of 3 Techniques for Ultrasound-guided Femoral Nerve Catheter Insertion

Comparison Between Ultrasound Guided Femoral Nerve Block Versus Ultrasound Guided Femoral Nerve Block With the Use of Peripheral Nerve Stimulation for Patients Undergoing Total Knee Replacement.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00927368
Enrollment
453
Registered
2009-06-25
Start date
2009-08-31
Completion date
2012-12-31
Last updated
2017-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Replacement Surgery

Keywords

TKA, total knee replacement

Brief summary

This is a randomized study which will compare three femoral nerve catheter insertion techniques. Subjects will be randomized into one of thee groups, Group 1: ultrasound guided femoral nerve catheter using a stimulation needle and stimulating catheter, .Group 2: ultrasound guided femoral nerve catheter using a stimulation needle, but non-stimulating catheter, or Group 3: ultrasound guided femoral nerve block without stimulation.

Detailed description

This is a randomized study which will compare three femoral nerve catheter insertion techniques. Subjects will be randomized into one of thee groups, Group 1: ultrasound guided femoral nerve catheter using a stimulation needle and stimulating catheter, .Group 2: ultrasound guided femoral nerve catheter using a stimulation needle, but non-stimulating catheter, or Group 3: ultrasound guided femoral nerve block without stimulation. * Pain Scores after surgery with be measured using the VAS (Visual Analogue Scale). Subjects will be asked to rate their pain on a scale of 1-10. * Block Performance time is the time from starting the block (after prepping and draping) until catheter is placed. * Opioid requirements will be measured as the total amount of opioids (converted to morphine sulfate equivalents) used both during surgery, and during the first 48 hours after surgery. * Block failure rate will be calculated as the rate of cases that requires repeating the block after surgery.

Interventions

PROCEDUREultrasound guidance alone

The Tuohy needle was inserted in out-plane approach. Needle placement was considered adequate when the tip was visualized beneath the fascia iliaca; the catheter was then introduced 5 cm beyond the needle tip. Electrical stimulation was not used.

PROCEDUREultrasound guidance and needle stimulation

For the ultrasound guidance and needle stimulation group, the Tuohy needle was positioned with the tip beneath the fascia iliaca under ultrasound guidance. The needle tip was then adjusted as necessary to obtain a quadriceps muscle response with a stimulating current ≤0.5 mA (2 Hz, pulse width 0.1 msec). Subsequently, the catheter was threaded 5 cm beyond the needle tip without additional electrical stimulation.

PROCEDUREultrasound guidance and catheter stimulation

The Tuohy needle was positioned with the tip beneath the fascia iliaca under ultrasound guidance. The needle tip was then adjusted as necessary to obtain a quadriceps muscle response with a stimulating current ≤0.5 mA. At that point, the peripheral nerve stimulator was then disconnected from the stimulating needle and connected to the proximal end of the catheter. The catheter was then advanced 5 cm past the needle tip. If the motor response disappeared during catheter advancement, the catheter was withdrawn slightly until the response returned. Needle orientation and catheter advancement were adjusted as necessary to elicit quadriceps contractions via the catheter with a stimulating current ≤0.5 mA.

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 80 years old at time of surgery. * Male or female patients undergoing total knee replacement under either general or neuraxial anesthesia (spinal or epidural). Intraoperative, patients will receive spinal anesthetics with 15 mg bupivacaine and 25mcg of fentanyl intrathecally.

Exclusion criteria

* Current or recent drug abuse (within past 6 months). * Pregnancy. * Patient refuses regional analgesia.

Design outcomes

Primary

MeasureTime frameDescription
Time Weighted Average Verbal Response Scale Pain Score48 hours after surgeryTime weighted average of verbal response scale (VRS) pain score on a scale from 0 (no pain) to 10 (worst pain imaginable). Verbal Response Scale (VRS) pain scores after surgery - which ranged from 0 (no pain) to 10 (maximum intolerable pain) - were assessed every 30 minutes in the recovery area and every 4 hours thereafter up to 48 hours postoperatively. These individual measurements were averaged for each patient using a time-weighted formula. (For a given patient, the observed VRS pain score profile as a function of time was linearly interpolated and integrated using the trapezoidal rule; then, the time-weighted average was calculated as the value of this integral divided by the total monitoring time of 48 hours.).
Opioid Consumption48 hours after surgerycumulative opioid consumption, where all opioids were converted to IV morphine equivalents

Secondary

MeasureTime frameDescription
Block Performance Timetime elapsed from beginning the block to catheter placementBlock performance time, defined as the time from block start until catheter placement.
Incremental Cost of Femoral Nerve Blockspostoperative period when block is usedThe incremental cost between strategies was calculated as the additional cost of one strategy to the next less costly strategy. There was no variance in the price because these prices were contracted with the hospital. The contracted price for a hospital does not change or fluctuate.

Countries

United States

Participant flow

Participants by arm

ArmCount
Ultrasound Guidance Alone
The Tuohy needle was inserted in out-plane approach. Needle placement was considered adequate when the tip was visualized beneath the fascia iliaca; the catheter was then introduced 5 cm beyond the needle tip. Electrical stimulation was not used. ultrasound guidance alone: The Tuohy needle was inserted in out-plane approach. Needle placement was considered adequate when the tip was visualized beneath the fascia iliaca; the catheter was then introduced 5 cm beyond the needle tip. Electrical stimulation was not used.
147
Ultrasound Guidance Needle Stimulation
For the ultrasound guidance and needle stimulation arm, the Tuohy needle was positioned with the tip beneath the fascia iliaca under ultrasound guidance. The needle tip was then adjusted as necessary to obtain a quadriceps muscle response with a stimulating current ≤0.5 mA (2 Hz, pulse width 0.1 msec). Subsequently, the catheter was threaded 5 cm beyond the needle tip without additional electrical stimulation ultrasound guidance and needle stimulation: For the ultrasound guidance and needle stimulation group, the Tuohy needle was positioned with the tip beneath the fascia iliaca under ultrasound guidance. The needle tip was then adjusted as necessary to obtain a quadriceps muscle response with a stimulating current ≤0.5 mA (2 Hz, pulse width 0.1 msec). Subsequently, the catheter was threaded 5 cm beyond the needle tip without additional electrical stimulation.
152
Ultrasound Guidance+Catheter Stimulation
For the ultrasound guidance and catheter stimulation group, the Tuohy needle was positioned with the tip beneath the fascia iliaca under ultrasound guidance. The needle tip was then adjusted as necessary to obtain a quadriceps muscle response with a stimulating current ≤0.5 mA. At that point, the peripheral nerve stimulator was then disconnected from the stimulating needle and connected to the proximal end of the catheter. The catheter was then advanced 5 cm past the needle tip. If the motor response disappeared during catheter advancement, the catheter was withdrawn slightly until the response returned. Needle orientation and catheter advancement were adjusted as necessary to elicit quadriceps contractions via the catheter with a stimulating current ≤0.5 mA.
138
Total437

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall Studycancellation of surgery012
Overall Studyenrollment in another study112
Overall Studyequipment failure100
Overall Studyineligible post randomization031
Overall StudyLost to Follow-up400

Baseline characteristics

CharacteristicUltrasound Guidance AloneUltrasound Guidance Needle StimulationUltrasound Guidance+Catheter StimulationTotal
Age, Continuous62 years
STANDARD_DEVIATION 9
61 years
STANDARD_DEVIATION 13
63 years
STANDARD_DEVIATION 9
62 years
STANDARD_DEVIATION 10
Sex: Female, Male
Female
80 Participants80 Participants76 Participants236 Participants
Sex: Female, Male
Male
67 Participants72 Participants62 Participants201 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 1470 / 1520 / 138
serious
Total, serious adverse events
0 / 1470 / 1520 / 138

Outcome results

Primary

Opioid Consumption

cumulative opioid consumption, where all opioids were converted to IV morphine equivalents

Time frame: 48 hours after surgery

ArmMeasureValue (MEDIAN)
Ultrasound Guidance AloneOpioid Consumption57 mg morphine equivalents
Ultrasound Guidance Needle StimulationOpioid Consumption58 mg morphine equivalents
Ultrasound Guidance+Catheter StimulationOpioid Consumption55 mg morphine equivalents
Comparison: The primary analysis for opioid was a linear regression model comparing stimulating catheter to stimulating needle on the log of cumulative opioid consumption score for a patient in the first 48 hours.p-value: 0.0495% CI: [-17, 34]t-test, 2 sided
Comparison: The primary analysis for opioid was a linear regression model comparing stimulating needle to stimulating catheter on the log of cumulative opioid consumption score for a patient in the first 48 hours.p-value: 0.00295% CI: [-25, 21]t-test, 2 sided
Comparison: The primary analysis for opioid was a linear regression model comparing stimulating catheter to ultrasound alone on the log of cumulative opioid consumption score for a patient in the first 48 hours.p-value: 0.0395% CI: [-25, 21]t-test, 2 sided
Comparison: The primary analysis for opioid was a linear regression model comparing ultrasound alone to stimulating catheter on the log of cumulative opioid consumption score for a patient in the first 48 hours.p-value: 0.00595% CI: [-24, 23]t-test, 2 sided
Comparison: The primary analysis for opioid was a linear regression model comparing stimulating needle to ultrasound alone on the log of cumulative opioid consumption score for a patient in the first 48 hours.p-value: 0.00695% CI: [-22, 25]t-test, 2 sided
Comparison: The primary analysis for opioid was a linear regression model comparing ultrasound alone to stimulating needle on the log of cumulative opioid consumption score for a patient in the first 48 hours.p-value: 0.0295% CI: [-20, 29]t-test, 2 sided
Primary

Time Weighted Average Verbal Response Scale Pain Score

Time weighted average of verbal response scale (VRS) pain score on a scale from 0 (no pain) to 10 (worst pain imaginable). Verbal Response Scale (VRS) pain scores after surgery - which ranged from 0 (no pain) to 10 (maximum intolerable pain) - were assessed every 30 minutes in the recovery area and every 4 hours thereafter up to 48 hours postoperatively. These individual measurements were averaged for each patient using a time-weighted formula. (For a given patient, the observed VRS pain score profile as a function of time was linearly interpolated and integrated using the trapezoidal rule; then, the time-weighted average was calculated as the value of this integral divided by the total monitoring time of 48 hours.).

Time frame: 48 hours after surgery

ArmMeasureValue (MEAN)Dispersion
Ultrasound Guidance AloneTime Weighted Average Verbal Response Scale Pain Score3.52 units on a scaleStandard Deviation 1.62
Ultrasound Guidance Needle StimulationTime Weighted Average Verbal Response Scale Pain Score3.24 units on a scaleStandard Deviation 1.55
Ultrasound Guidance+Catheter StimulationTime Weighted Average Verbal Response Scale Pain Score3.40 units on a scaleStandard Deviation 1.47
Comparison: The primary analysis for pain was a linear regression model comparing stimulating needle to stimulating catheter on the mean time-weighted average pain score for a patient in the first 48 hours.p-value: <0.00195% CI: [-0.61, 0.29]t-test, 2 sided
Comparison: The primary analysis for pain was a linear regression model comparing stimulating catheter to stimulating needle on the mean time-weighted average pain score for a patient in the first 48 hours.p-value: 0.0395% CI: [-0.29, 0.61]t-test, 2 sided
Comparison: The primary analysis for pain was a linear regression model comparing stimulating catheter to ultrasound alone on the mean time-weighted average pain score for a patient in the first 48 hours.p-value: <0.00195% CI: [-0.57, 0.33]t-test, 2 sided
Comparison: The primary analysis for pain was a linear regression model comparing ultrasound alone to stimulating catheter on the mean time-weighted average pain score for a patient in the first 48 hours.p-value: 0.0295% CI: [-0.33, 0.57]t-test, 2 sided
Comparison: The primary analysis for pain was a linear regression model comparing stimulating needle to ultrasound alone on the mean time-weighted average pain score for a patient in the first 48 hours.p-value: <0.00195% CI: [-0.72, 0.16]t-test, 2 sided
Comparison: The primary analysis for pain was a linear regression model comparing ultrasound alone to stimulating needle on the mean time-weighted average pain score for a patient in the first 48 hours.p-value: 0.1195% CI: [-0.16, 0.72]t-test, 2 sided
Secondary

Block Performance Time

Block performance time, defined as the time from block start until catheter placement.

Time frame: time elapsed from beginning the block to catheter placement

ArmMeasureValue (MEAN)
Ultrasound Guidance AloneBlock Performance Time110 seconds
Ultrasound Guidance Needle StimulationBlock Performance Time150 seconds
Ultrasound Guidance+Catheter StimulationBlock Performance Time177 seconds
Comparison: Stimulating needle versus stimulating catheter.p-value: 0.11ANOVA
Comparison: Stimulating needle versus ultrasound guidance alonep-value: 0.0195% CI: [6, 75]ANOVA
Comparison: Stimulating catheter versus ultrasound guidance alonep-value: <0.00195% CI: [31, 102]ANOVA
Secondary

Incremental Cost of Femoral Nerve Blocks

The incremental cost between strategies was calculated as the additional cost of one strategy to the next less costly strategy. There was no variance in the price because these prices were contracted with the hospital. The contracted price for a hospital does not change or fluctuate.

Time frame: postoperative period when block is used

ArmMeasureValue (MEAN)Dispersion
Ultrasound Guidance AloneIncremental Cost of Femoral Nerve Blocks14 dollarsStandard Deviation 0
Ultrasound Guidance Needle StimulationIncremental Cost of Femoral Nerve Blocks36 dollarsStandard Deviation 0
Ultrasound Guidance+Catheter StimulationIncremental Cost of Femoral Nerve Blocks50 dollarsStandard Deviation 0
Comparison: We calculated incremental cost, defined as the additional cost of one strategy to the next less costly strategy.
Comparison: We calculated incremental cost, defined as the additional cost of one strategy to the next less costly strategy.
Comparison: We calculated incremental cost, defined as the additional cost of one strategy to the next less costly strategy.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026